Drug resistance and HCV coinfection in former blood donors infected with HIV type 1 in China

AIDS Res Hum Retroviruses. 2011 Aug;27(8):925-30. doi: 10.1089/aid.2010.0328. Epub 2011 Jan 15.

Abstract

Unhygienic blood collection caused an outbreak of HIV-1 and HCV infections among blood donors in rural areas in Henan province, China. Partial HIV-1 pol and HCV NS5b gene sequences were obtained from 97 persons infected with HIV-1 to determine the efficacy of treatment, the prevalence of drug-resistant mutations, and the impact of HCV infection on disease progression of infection with HIV-1. After antiretroviral therapy, 60 out of 97 HIV-1-infected blood donors had their HIV-1 RNA levels reduced to an undetectable level. Drug-resistant mutations to reverse transcriptase inhibitors were detected in one-third of treatment failure patients, with K103N as the most frequent mutation. Drug-resistant mutations were not detected in the other two-thirds of treatment-failure patients, suggesting a poor adherence to the treatment. The majority of HIV-1-infected patients (91.8%) were also infected with HCV. Sequence analysis showed that they were infected with HCV subtype 1b (47.5%) or 2a (52.5%). HCV viral loads were significantly higher in patients infected with subtype 2a than in patients infected with HCV subtype 1b, although no differences in HIV-1 viral loads and CD4(+)T cell counts was observed between the two subtypes. These results suggest that improved adherence and treatment regimens will be critical to effectively treat HIV-1 and HCV-coinfected patients in resource-limited areas.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiretroviral Therapy, Highly Active
  • Blood Donors
  • CD4 Lymphocyte Count
  • China
  • Disease Progression
  • Drug Resistance, Viral / drug effects
  • Drug Resistance, Viral / genetics*
  • Female
  • Genes, pol
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • HIV Infections / epidemiology
  • HIV Infections / virology
  • HIV-1 / drug effects
  • HIV-1 / genetics*
  • Hepacivirus / drug effects
  • Hepacivirus / genetics*
  • Hepatitis C / complications
  • Hepatitis C / drug therapy*
  • Hepatitis C / epidemiology
  • Hepatitis C / virology
  • Humans
  • Male
  • Middle Aged
  • Mutation
  • Patient Compliance
  • Phylogeny
  • Prevalence
  • RNA-Directed DNA Polymerase / metabolism*
  • Reverse Transcriptase Inhibitors / pharmacology
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Treatment Outcome
  • Viral Load

Substances

  • Reverse Transcriptase Inhibitors
  • RNA-Directed DNA Polymerase